Literature DB >> 30624592

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

G Curigliano, H J Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, M Colleoni, M M Regan, M Piccart-Gebhart, H-J Senn, B Thürlimann.   

Abstract

Entities:  

Year:  2019        PMID： 30624592      PMCID： PMC6637369          DOI： 10.1093/annonc/mdy537

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  17 in total

1.  Bisphosphonate Choice as Adjuvant Therapy for Breast Cancer: Does it Matter?

Authors:  Adam Brufsky; Aju Mathew
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

2.  Comparison of two different surgical strategies for breast cancer patients treated with mastectomy plus sentinel lymph node biopsy.

Authors:  Xing Zhang; Qian Shen; Yu-Jie Hu
Journal:  Updates Surg       Date:  2021-06-10

3.  Predictive factors of pathologically node-negative disease for HER2 positive and triple-negative breast cancer after neoadjuvant therapy.

Authors:  Zhiqiang Shi; Xueer Wang; Pengfei Qiu; Yanbing Liu; Tong Zhao; Xiao Sun; Peng Chen; Chunjian Wang; Zhaopeng Zhang; Binbin Cong; Yongsheng Wang
Journal:  Gland Surg       Date:  2021-01

Review 4.  Towards Circulating-Tumor DNA-Based Precision Medicine.

Authors:  Ai Hironaka-Mitsuhashi; Anna Sanchez Calle; Takahiro Ochiya; Shin Takayama; Akihiko Suto
Journal:  J Clin Med       Date:  2019-09-02       Impact factor: 4.241

5.  Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.

Authors:  Olivia Pagani; Prudence A Francis; Gini F Fleming; Barbara A Walley; Giuseppe Viale; Marco Colleoni; István Láng; Henry L Gómez; Carlo Tondini; Graziella Pinotti; Angelo Di Leo; Alan S Coates; Aron Goldhirsch; Richard D Gelber; Meredith M Regan
Journal:  J Clin Oncol       Date:  2019-10-16       Impact factor: 44.544

6.  Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients.

Authors:  Cynthia Villarreal-Garza; Edna Anakarenn Lopez-Martinez; Zuratzi Deneken-Hernandez; Antonio Maffuz-Aziz; Jose Felipe Muñoz-Lozano; Regina Barragan-Carrillo; Pier Ramos-Elias; Brizio Moreno; Hector Diaz-Perez; Omar Peña-Curiel; Jose de Jesus Curiel-Valdez; Veronica Bautista-Piña
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

7.  Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts.

Authors:  Nina Oparina; Malin C Erlandsson; Anna Fäldt Beding; Toshima Parris; Khalil Helou; Per Karlsson; Zakaria Einbeigi; Maria I Bokarewa
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

8.  Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.

Authors:  Yuhong Huang; Wenben Chen; Xiaoling Zhang; Shaofu He; Nan Shao; Huijuan Shi; Zhenzhe Lin; Xueting Wu; Tongkeng Li; Haotian Lin; Ying Lin
Journal:  Front Bioeng Biotechnol       Date:  2021-07-06

Review 9.  Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy.

Authors:  Roberto Lo Gullo; Sarah Eskreis-Winkler; Elizabeth A Morris; Katja Pinker
Journal:  Breast       Date:  2019-11-23       Impact factor: 4.380

10.  Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal-type breast cancer.

Authors:  Takafumi Suzuki; Yoji Yamagishi; Takahiro Einama; Tomomi Koiwai; Tamio Yamasaki; Makiko Fukumura-Koga; Yusuke Ishibashi; Yasuhiro Takihata; Takehiro Shiraishi; Yoichi Miyata; Toshimitsu Iwasaki; Eiji Shinto; Kimiya Sato; Hideki Ueno; Junji Yamamoto; Yoji Kishi; Hitoshi Tsuda
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.